Basel, Switzerland-February 12, 2018-The Children’s Emergency Hospital "Louis Turcanu" (Spitalul Clinic de Urgenta pentru Copii „Louis Èurcanu”), in TimiÈoara, is the first hospital in Clinerion’s PRS network which specializes in pediatric care, opening up PRS to more expert research in the field. The "Louis Turcanu" hospital is the leading pediatric healthcare facility in Western Romania. Founded in 1903, it offers a variety of professional activities covering the full range of pediatric specialties. It has more than 500 beds and 8 principal investigators running more than 20 clinical studies per year. By joining Clinerion’s PRS platform, the "Louis Turcanu" hospital will benefit from improved access to leading-edge sponsored clinical trials run by international pharmaceutical companies and contract research organizations. The hospital’s investigators will reap huge time savings during site evaluation and when screening for eligible patients for studies. Their patients will gain early access to innovative medication and more options for treatments. They will also benefit from PRS’ ability to query their own patient database with complex criteria via a simple web interface without compromising patient privacy. “Our hospital has a long history of leadership in children’s health and we continue to contribute to the development of pediatric medicine by running studies for clinical research. PRS offers us exposure to more research which is innovative and international in scale,” says Dr. Adam Ovidiu, Manager of Louis Turcanu. “The beauty of Clinerion’s network is that we are able to propose trial sites around the world and with a plethora of specializations to sponsors. We are thrilled to add the Children’s Emergency Hospital "Louis Turcanu" and its expert pediatric clinicians to PRS,” says Ulf Claesson, CEO of Clinerion. About Clinerion Clinerion enables early patient access to innovative treatments through solutions for clinical trial patient recruitment, real-world evidence, and market access. Clinerion's PRS accelerates clinical research by radically improving the efficiency and effectiveness of trial recruitment. Clinerion’s key patient data services include data-assisted protocol optimization, site feasibility evaluation and patient identification. Clinerion’s solutions allow member hospitals to participate in leading-edge, industry-sponsored trials and save time in patient recruitment. They enable pharmaceutical companies to gain time and save costs by streamlining operations and leveraging strategic intelligence. Clinerion’s proprietary Big Data analytics technologies leverage real-time data from electronic health records which remain under the full control of participating hospitals. Clinerion is a global data technology service company headquartered in Switzerland. Clinerion's solutions comply with international patient privacy and data security regulations. Clinerion website: www.clinerion.com Clinerion’s PRS: www.clinerion.com/index/OverviewOurSolutions/PatientRecruitmentSystem For more information, please contact: Le Vin Chin Head of Marketing and Communications Clinerion Ltd Margarethenstrasse 47, CH-4053 Basel, Switzerland Tel.: +41 61 865 60 54 media@clinerion.com
FDA Approves Nipocalimab for the Treatment of Generalized Myasthenia Gravis
April 30th 2025Approval is based on results from the pivotal Vivacity-MG3 trial in which IMAAVY (nipocalimab-aahu) demonstrated superior disease control throughout 24 weeks when compared to placebo plus standard of care.
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.